Nationwide surveillance of antimicrobial resistance in invasive isolates of Streptococcus pneumoniae in Taiwan from 2017 to 2019

CONCLUSION: Empirical treatment with ceftriaxone monotherapy for pneumococcal meningitis should be carefully monitored owing to its high non-susceptibility rate. The susceptibility rates of most isolates to penicillin (used for treating non-meningitis pneumococcal diseases), carbapenems (ertapenem and doripenem), respiratory quinolones (moxifloxacin and levofloxacin), vancomycin, and linezolid suggested the potential of these antibiotics in treating pneumococcal diseases in Taiwan.PMID:34219043 | DOI:10.1016/j.jmii.2021.05.008

Source: Journal of Microbiology, Immunology, and Infection - July 5, 2021 Category: Microbiology Authors: Yu-Te Tsai Yu-Lin Lee Min-Chi Lu Pei-Lan Shao Po-Liang Lu Shu-Hsing Cheng Wen-Chien Ko Chi-Ying Lin Ting-Shu Wu Muh-Yong Yen Lih-Shinn Wang Chang-Pan Liu Wen-Sen Lee Zhi-Yuan Shi Yao-Shen Chen Fu-Der Wang Shu-Hui Tseng Chao-Nan Lin Yu-Hui Chen Wang-Huei S Source Type: research